Overview of modern GLP-1based medicines and type 2 diabetes GLP1RAs like exenatide, liraglutide, semaglutide, and tirzepatide are widely used for type 2 diabetes and obesity, offering significant benefits in glucose control, weight loss, and cardiovascular health
doi: 10.1016/j.jhep.2019.06.018 42 HouGChenLLiuGLiLYangYYanHXet al
Liraglutide and semaglutide are long-acting human GLP-1 analogues with high receptor affinity and sustained receptor occupancy, whereas dulaglutide is a larger fusion molecule conjugated to an IgG4 Fc fragment, resulting in distinct pharmacokinetics and tissue distribution
found significant reductions in apathy and depressive symptoms within the same cohort, with lower NMSS mood/apathy scores ( p = 0.026), better MDS-UPDRS Part I mood item scores ( p = 0.034), and a markedly reduced prevalence of depression and apathy [59]
TRaQ-GmGold was calibrated to measure the absolute GSH concentration of specific subcellular compartments in living cells
The degradation of oxidized glutathione (GSSG) involves NADPH-dependent glutathione reductase (Pei et al